Biosims Technologies Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Liquidation

Biosims Technologies General Information

Description

Developer and manufacturer of high-performance analytical tools for life science industries. The company's Dynaxi detection platform, its software and kits allows extremely low amounts of targets in a sample to be monitored, at a level never reached so far on a chip device.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Technology Systems
Corporate Office
  • Seine biopolis II
  • 75, Route de Lyons la forêt
  • 76000 Rouen
  • France
+33 09 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosims Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Bankruptcy: Liquidation 27-Dec-2016 00.000 Completed Bankruptcy: Liquidation
5. Early Stage VC 01-Apr-2016 00000 00.000 00.000 Completed Startup
4. Early Stage VC 22-May-2015 00.000 00.000 00.000 Completed Startup
3. Seed Round 12-Dec-2013 00000 00000 00000 Completed Startup
2. Debt - General Completed Startup
1. Grant Completed Startup
To view Biosims Technologies’s complete valuation and funding history, request access »

Biosims Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series P2 0,000 00.000000 000.0 000.0 00 000.0 0.000
Series P1 00,000 00.000000 000.0 000.0 00 000.0 0.000
Ordinary 000 00.000000 000.00 000.00 00 000.00 0.000
Series P2 0,000 00.000000 000.0 000.0 00 000.0 0.000
Series P2 0,000 00.000000 000.0 000.0 00 000.0 0.000
Series P1 39,583 $1.116636 $26.8 $26.8 1x $26.8 35.52%
Ordinary 10,000 $1.116636 $11.17 $11.17 1x $11.17 8.97%
To view Biosims Technologies’s complete cap table history, request access »

Biosims Technologies Patents

Biosims Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3023792-A1 Spot control Inactive 18-Nov-2014 00000000000 0
EP-2684044-A1 Method for detection and quantification of target biomolecules Inactive 10-Mar-2011 00000000000
CA-2828431-A1 Method for detection and quantification of target biomolecules Inactive 10-Mar-2011 00000000000
US-20120172249-A1 Method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) Inactive 15-Sep-2009 00000000000 0
CA-2774125-A1 Improved method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) Inactive 15-Sep-2009 G01N33/6848
To view Biosims Technologies’s complete patent history, request access »

Biosims Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosims Technologies FAQs

  • When was Biosims Technologies founded?

    Biosims Technologies was founded in 2010.

  • Who is the founder of Biosims Technologies?

    Guillaume Legent Ph.D and Christine Oden are the founders of Biosims Technologies.

  • Where is Biosims Technologies headquartered?

    Biosims Technologies is headquartered in Rouen, France.

  • What is the size of Biosims Technologies?

    Biosims Technologies has 11 total employees.

  • What industry is Biosims Technologies in?

    Biosims Technologies’s primary industry is Biotechnology.

  • Is Biosims Technologies a private or public company?

    Biosims Technologies is a Private company.

  • What is Biosims Technologies’s current revenue?

    The current revenue for Biosims Technologies is 000000.

  • How much funding has Biosims Technologies raised over time?

    Biosims Technologies has raised $1.92M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »